← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Warby Parker Inc. (WRBY) 10-Year Financial Performance & Capital Metrics

WRBY • • Industrial / General
HealthcareMedical InstrumentsOphthalmic Devices & Vision CareContact Lenses & Vision Correction
AboutWarby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.Show more
  • Revenue $771M +15.2%
  • EBITDA $16M +147.1%
  • Net Income -$20M +67.7%
  • EPS (Diluted) -0.17 +68.5%
  • Gross Margin 55.34% +1.5%
  • EBITDA Margin 2.04% +140.9%
  • Operating Margin -3.9% +63.7%
  • Net Margin -2.64% +72.0%
  • ROE -6.35% +70.4%
  • ROIC -7.92% +62.6%
  • Debt/Equity 0.66 +14.6%
  • Interest Coverage -
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 84 (top 16%)
  • ✓Strong 5Y sales CAGR of 15.8%
  • ✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

  • ✗Expensive at 10.0x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y15.8%
3Y12.56%
TTM14.55%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM102.2%

EPS CAGR

10Y-
5Y-
3Y-
TTM101.25%

ROCE

10Y Avg-20.29%
5Y Avg-24.02%
3Y Avg-17.12%
Latest-6.03%

Peer Comparison

Contact Lenses & Vision Correction
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
COOThe Cooper Companies, Inc.16.13B82.3144.025.06%10.08%4.88%2.69%0.34
LUCYInnovative Eyewear, Inc.8.19M1.53-0.2941.99%-770.01%-17.97%
BLCOBausch + Lomb Corporation6.18B17.44-19.3815.56%-6.13%-4.69%0.75
STAASTAAR Surgical Company1.04B20.97-51.15-2.64%-41.79%-27.24%0.10
WRBYWarby Parker Inc.3B28.33-166.6515.16%0.08%0.19%1.16%0.66

Profit & Loss

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+370.46M393.72M540.8M598.11M669.76M771.32M
Revenue Growth %-0.06%0.37%0.11%0.12%0.15%
Cost of Goods Sold+147.35M161.78M223.05M257.05M304.54M344.48M
COGS % of Revenue0.4%0.41%0.41%0.43%0.45%0.45%
Gross Profit+223.11M231.94M317.75M341.06M365.22M426.83M
Gross Margin %0.6%0.59%0.59%0.57%0.55%0.55%
Gross Profit Growth %-0.04%0.37%0.07%0.07%0.17%
Operating Expenses+224.77M287.57M461.41M452.26M437.22M456.95M
OpEx % of Revenue0.61%0.73%0.85%0.76%0.65%0.59%
Selling, General & Admin224.77M287.57M461.41M452.26M421.57M440.05M
SG&A % of Revenue0.61%0.73%0.85%0.76%0.63%0.57%
Research & Development000000
R&D % of Revenue------
Other Operating Expenses000015.65M16.89M
Operating Income+-1.66M-55.63M-143.66M-111.2M-72M-30.11M
Operating Margin %-0%-0.14%-0.27%-0.19%-0.11%-0.04%
Operating Income Growth %--32.45%-1.58%0.23%0.35%0.58%
EBITDA+12.85M-37.26M-121.7M-79.34M-33.44M15.75M
EBITDA Margin %0.03%-0.09%-0.23%-0.13%-0.05%0.02%
EBITDA Growth %--3.9%-2.27%0.35%0.58%1.47%
D&A (Non-Cash Add-back)14.52M18.38M21.96M31.86M38.55M45.87M
EBIT-1.66M-55.63M-143.66M-109.9M-72M-30.11M
Net Interest Income+1.94M-97K01.31M9.23M10.6M
Interest Income1.94M001.31M9.23M10.6M
Interest Expense097K0000
Other Income/Expense1.94M-97K-347K1.31M9.23M10.6M
Pretax Income+276K-55.73M-144.01M-109.9M-62.76M-19.52M
Pretax Margin %0%-0.14%-0.27%-0.18%-0.09%-0.03%
Income Tax+276K190K263K497K433K875K
Effective Tax Rate %-1%1%1%1.01%1.04%
Net Income+0-55.92M-144.27M-110.39M-63.2M-20.39M
Net Margin %--0.14%-0.27%-0.18%-0.09%-0.03%
Net Income Growth %---1.58%0.23%0.43%0.68%
Net Income (Continuing)0-55.92M-144.27M-110.39M-63.2M-20.39M
Discontinued Operations000000
Minority Interest000000
EPS (Diluted)+-0.52-0.50-1.39-0.96-0.54-0.17
EPS Growth %-0.04%-1.78%0.31%0.44%0.69%
EPS (Basic)-0.52-0.50-1.39-0.96-0.54-0.17
Diluted Shares Outstanding111.39M111.39M113.62M114.94M117.39M120.39M
Basic Shares Outstanding111.39M111.39M113.62M114.94M117.39M120.39M
Dividend Payout Ratio------

Balance Sheet

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+91.68M359.93M327.98M294.57M298.62M326.05M
Cash & Short-Term Investments55.42M314.08M256.42M208.59M216.89M254.16M
Cash Only55.42M314.08M256.42M208.59M216.89M254.16M
Short-Term Investments000000
Accounts Receivable1.12M601K992K1.44M1.78M1.95M
Days Sales Outstanding1.10.560.670.880.970.92
Inventory28.44M38.47M57.09M68.85M62.23M52.34M
Days Inventory Outstanding70.4486.7993.4397.7674.5955.46
Other Current Assets00015.7M17.71M17.59M
Total Non-Current Assets+84.17M84.82M112.67M274.14M281.69M350.44M
Property, Plant & Equipment83.89M84.53M112.19M265.64M274.64M341.75M
Fixed Asset Turnover4.42x4.66x4.82x2.25x2.44x2.26x
Goodwill000000
Intangible Assets3.7M3.6M8.6M000
Long-Term Investments000002M
Other Non-Current Assets-3.42M-3.32M-8.13M8.5M7.06M6.7M
Total Assets+175.86M444.75M440.65M568.71M580.31M676.49M
Asset Turnover2.11x0.89x1.23x1.05x1.15x1.14x
Asset Growth %-1.53%-0.01%0.29%0.02%0.17%
Total Current Liabilities+75.87M105.33M118.1M129.56M127.09M130.35M
Accounts Payable37.31M40.79M30.89M20.79M22.46M23.52M
Days Payables Outstanding92.4192.0250.5529.5226.9124.92
Short-Term Debt000000
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K
Other Current Liabilities15.59M30.09M53.29M2.37M2.41M54.24M
Current Ratio1.21x3.42x2.78x2.27x2.35x2.50x
Quick Ratio0.83x3.05x2.29x1.74x1.86x2.10x
Cash Conversion Cycle-20.87-4.6843.5569.1148.6431.46
Total Non-Current Liabilities+26.59M31.01M36.54M152.5M151.44M206.06M
Long-Term Debt000000
Capital Lease Obligations000150.83M150.17M205.12M
Deferred Tax Liabilities000000
Other Non-Current Liabilities26.59M31.01M36.54M1.67M1.26M943K
Total Liabilities102.46M136.34M154.65M282.06M278.52M336.42M
Total Debt+000173.38M174.46M225.35M
Net Debt-55.42M-314.08M-256.42M-35.21M-42.44M-28.81M
Debt / Equity---0.60x0.58x0.66x
Debt / EBITDA-----14.31x
Net Debt / EBITDA-4.31x-----1.83x
Interest Coverage--573.53x----
Total Equity+73.4M308.41M286M286.65M301.79M340.07M
Equity Growth %-3.2%-0.07%0%0.05%0.13%
Book Value per Share0.662.772.522.492.572.82
Total Shareholders' Equity73.4M308.41M286M286.65M301.79M340.07M
Common Stock5K5K11K12K12K12K
Retained Earnings-269.47M-325.39M-493.24M-603.63M-666.83M-687.22M
Treasury Stock000000
Accumulated OCI22K109K16K-647K-1.53M-1.94M
Minority Interest000000

Cash Flow

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+21.39M32.76M-31.99M10.37M60.99M98.74M
Operating CF Margin %0.06%0.08%-0.06%0.02%0.09%0.13%
Operating CF Growth %-0.53%-1.98%1.32%4.88%0.62%
Net Income0-55.92M-144.27M-110.39M-63.2M-20.39M
Depreciation & Amortization14.52M18.38M21.87M31.86M38.55M45.87M
Stock-Based Compensation8.5M44.91M107.15M98.03M70.51M0
Deferred Taxes0-85.27M0000
Other Non-Cash Items085.27M7.76M5.42M9.32M54.01M
Working Capital Changes-1.62M25.39M-24.5M-14.55M5.81M19.26M
Change in Receivables-644K517K-392K-451K-345K-169K
Change in Inventory-12.61M-10.02M-18.62M-11.79M6.61M9.89M
Change in Payables5.53M5.9M-11.11M-7.94M1.63M689K
Cash from Investing+-32.63M-20.07M-48.51M-60.18M-54.67M-66.03M
Capital Expenditures-32.63M-20.07M-48.51M-60.18M-53.67M-64.03M
CapEx % of Revenue0.09%0.05%0.09%0.1%0.08%0.08%
Acquisitions------
Investments------
Other Investing000000
Cash from Financing+-83.36M245.94M23M3.29M2.87M4.96M
Debt Issued (Net)------
Equity Issued (Net)------
Dividends Paid000000
Share Repurchases------
Other Financing-4.48M0-528K00333K
Net Change in Cash------
Free Cash Flow+-11.24M12.69M-80.51M-49.81M7.32M34.71M
FCF Margin %-0.03%0.03%-0.15%-0.08%0.01%0.05%
FCF Growth %-2.13%-7.35%0.38%1.15%3.74%
FCF per Share-0.100.11-0.71-0.430.060.29
FCF Conversion (FCF/Net Income)--0.59x0.22x-0.09x-0.97x-4.84x
Interest Paid88K466K150K184K227K0
Taxes Paid369K230K356K536K419K0

Key Ratios

Metric201920202021202220232024
Return on Equity (ROE)--29.29%-48.54%-38.56%-21.48%-6.35%
Return on Invested Capital (ROIC)-6.94%-678.44%-901.26%-59.36%-21.14%-7.92%
Gross Margin60.22%58.91%58.76%57.02%54.53%55.34%
Net Margin--14.2%-26.68%-18.46%-9.44%-2.64%
Debt / Equity---0.60x0.58x0.66x
Interest Coverage--573.53x----
FCF Conversion--0.59x0.22x-0.09x-0.97x-4.84x
Revenue Growth-6.28%37.36%10.6%11.98%15.16%

Revenue by Segment

2021202220232024
Eyewear Products522.96M568.73M627.61M730.8M
Eyewear Products Growth-8.75%10.35%16.44%
Services And Other17.84M29.38M42.16M40.51M
Services And Other Growth-64.69%43.50%-3.91%

Frequently Asked Questions

Growth & Financials

Warby Parker Inc. (WRBY) reported $850.6M in revenue for fiscal year 2024. This represents a 130% increase from $370.5M in 2019.

Warby Parker Inc. (WRBY) grew revenue by 15.2% over the past year. This is strong growth.

Yes, Warby Parker Inc. (WRBY) is profitable, generating $0.7M in net income for fiscal year 2024 (-2.6% net margin).

Dividend & Returns

Warby Parker Inc. (WRBY) has a return on equity (ROE) of -6.4%. Negative ROE indicates the company is unprofitable.

Warby Parker Inc. (WRBY) generated $37.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.